Renalytix Plc
RTNXF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $11,051 | $17,332 | $39,939 | $18,384 |
| - Cash | $909 | $4,680 | $4,704 | $5,619 |
| + Debt | $8,253 | $8,535 | $9,419 | $8,484 |
| Enterprise Value | $18,395 | $21,187 | $44,654 | $21,249 |
| Revenue | $522 | $586 | $535 | $709 |
| % Growth | -10.9% | 9.5% | -24.5% | – |
| Gross Profit | $100 | $36 | -$66 | $229 |
| % Margin | 19.2% | 6.1% | -12.3% | 32.3% |
| EBITDA | -$4,032 | -$5,465 | -$6,067 | -$8,878 |
| % Margin | -772.4% | -932.6% | -1,134% | -1,252.2% |
| Net Income | -$4,728 | -$7,074 | -$7,743 | -$8,485 |
| % Margin | -905.7% | -1,207.2% | -1,447.3% | -1,196.8% |
| EPS Diluted | -0.04 | -0.051 | -0.079 | -0.09 |
| % Growth | 21.9% | 35.4% | 11.9% | – |
| Operating Cash Flow | -$3,836 | -$7,826 | -$4,862 | -$7,919 |
| Capital Expenditures | $0 | -$1 | -$3 | $0 |
| Free Cash Flow | -$3,836 | -$7,827 | -$4,865 | -$7,919 |